FDA warns companies for GMP violations, conducting trial without IND
Regulatory NewsJeff Craven
APIsAudit/FDA InspectionComplianceNorth AmericaNutritional/Natural HealthPharmaceuticalsRegulatory NewsJeff CravenAPIsAudit/FDA InspectionComplianceNorth AmericaNutritional/Natural HealthPharmaceuticals